Evidence map›Paper›PMID 40676585›Full record

ArticleBMC public health2025

Improving estimators of HIV mortality and retention in care by linking clinical cohort data with national registries in Mexico.

Lorena Guerrero-Torres, Bibiana Montserrat Barbosa-Ramírez, Pablo F Belaunzarán-Zamudio, Jesús Alegre-Díaz, Raúl Ramírez, Antonio Rosa-Parra, Juan Sierra-Madero, Brenda Crabtree-Ramírez, Yanink Caro Vega

Abstract read
In one paragraph

Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Lorena Guerrero-TorresDepartamento de Infectología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Vasco de Quiroga # 15, Ciudad de México, 14080, México.
Bibiana Montserrat Barbosa-RamírezDepartamento de Infectología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Vasco de Quiroga # 15, Ciudad de México, 14080, México.
Pablo F Belaunzarán-ZamudioDepartamento de Infectología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Vasco de Quiroga # 15, Ciudad de México, 14080, México.
Jesús Alegre-DíazGeneral Directorate of Epidemiology of Mexico, Mexico City, Mexico.
Raúl RamírezGeneral Directorate of Epidemiology of Mexico, Mexico City, Mexico.
Antonio Rosa-ParraCENSIDA, Mexico City, Mexico.
Juan Sierra-MaderoDepartamento de Infectología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Vasco de Quiroga # 15, Ciudad de México, 14080, México.
Brenda Crabtree-RamírezDepartamento de Infectología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Vasco de Quiroga # 15, Ciudad de México, 14080, México.
Yanink Caro VegaDepartamento de Infectología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Vasco de Quiroga # 15, Ciudad de México, 14080, México. yanink.caro@infecto.mx.

Funding

CCASAnet: Caribbean, Central and South America NetworkU01AI069923 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Pedro Enrique Cahn, Jessica L Castilho · 2006 to 2026
$41.6M
NIAID NIH HHS U01 AI069923NIH HHS U01AI069923
6 · The paper itself

Abstract

introductionLoss to follow-up (LTFU) bias mortality estimates in cohort studies. This study aimed to estimate the corrected incidence of LTFU, retention in care, and mortality rates in people with HIV (PWH) in an HIV/AIDS Clinic in Mexico City, by linking clinic and national registry data, and to identify characteristics associated with LTFU.

methodsWe linked adult PWH who met lost to follow-up criteria while enrolled at a Mexico City clinic with the national death registry, a national administrative HIV database and a clinical national registry in May 2019 and January 2021. We defined lost to follow-up as absence of a documented clinical contact in the previous 180 days. We estimated corrected LTFU, retention in care, mortality rates, and survival, and identified characteristics associated to LTFU.

resultsAmong 2,826 PWH followed by a median of 5.9 years (IQR: 1.9-7.1), 804 (28.4%) were lost and 149 (5.3%) died. After the second linkage, of the 804 lost, 257 (32%) died, 175 (21.8%) transferred, 40 (4.9%) were retained in care, and 332 (41.3%) remained LTFU. Post second linkage, the corrected cumulative proportion of LTFU slightly decreased (n = 764, 27%), but deaths substantially increased (n = 459, 16.2%). A subset of PWH transferred to other centres (n = 184, 6.5%). The unadjusted LTFU rate decreased from 4.0 to 2.9 per 100 person-years (PY), while mortality increased from 0.7 to 1.7 per 100 PY. Younger age (aHR 1.5, 95%CI 1.38-1.63 per 10-year change), and lower education (aHR 1.05, 95%CI 1.01-1.08 per year) were associated to a higher risk of LTFU.

conclusionDatasets linkages revealed mortality rates three times higher than the original estimates, highlighting the limitations of relying in single-source data. At the individual level, identifying predictors of LTFU can help target interventions to improve retention and may reduce mortality. However, at the system-level, our study demonstrates the feasibility and value of cross-institutional data linkage in fragmented health systems. Key lessons include the importance of long-term, privacy-preserving data-sharing collaboration between institutions to improve patient tracking across institutions, mortality surveillance and care continuity.

Indexed as

HIV InfectionsLost to Follow-UpRegistriesRetention in CareAdultCohort StudiesFemaleHumansMaleMexicoMiddle AgedContinuum of careLatin AmericaLinkageLTFUPatient tracking (5)

Identifiers

PMID40676585
PMCPMC12272977

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.